Prostate Cancer
Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancer.
November 19, 2024
[225Ac]Ac-PSMA for the treatment of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
November 19, 2024
Association between beta-blocker atenolol use and prostate cancer upgrading in active surveillance.
November 19, 2024
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer.
November 19, 2024
The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer.
November 19, 2024
St Vincent’s Hospital to Conduct Head-to-Head Trial with Clarity’s SAR-bisPSMA Diagnostic Product
November 18, 2024
Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers.
November 18, 2024
HSD3B1, prostate cancer mortality and modifiable outcomes.
November 18, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
November 18, 2024
Real-World Comparison of Cabazitaxel Versus 177Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer.
November 18, 2024
Striving for Equity: Examining Health Disparities in Urologic Oncology.
November 18, 2024
Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review.
November 15, 2024
Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort.
November 15, 2024
The Role of Nuclear Medicine in Imaging and Therapy of Prostate Cancer: The State of the Art.
November 15, 2024